Intervention group: IV Trehalose (15 g per week) for 12 weeks by Dr.Rajabi Pharmaceutical Co..

5 trials

Sponsors

Mashhad University of Medical Sciences

Conditions

Amiytrophic Lateral Sclerosis (ALS). Motor neuron diseaseCirrhosis of liver. Fibrosis and cirrhosis of liverMultiple Sclerosis. G35PSP (progressive supranuclear palsy). Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]Rheumatoid Arthritis. Other rheumatoid arthritis

Unknown Phase

Investigation the effect of trehalose on PSP

Active, not recruitingIRCT20181022041407N5

Mashhad University of Medical SciencesPSP (progressive supranuclear palsy). Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

Start: 2024-07-22Target: 1Updated: 2024-06-24

Investigation the effect of trehalose on ALS

Active, not recruitingIRCT20181022041407N6

Mashhad University of Medical SciencesAmiytrophic Lateral Sclerosis (ALS). Motor neuron disease

Start: 2024-07-22Target: 1Updated: 2024-06-24

Investigation the effect of trehalose on cirrhosis

RecruitingIRCT20181022041407N12

Mashhad University of Medical SciencesCirrhosis of liver. Fibrosis and cirrhosis of liver

Start: 2024-08-22Target: 1Updated: 2025-01-08

Investigation the effect of trehalose on Rheumatoid Arthritis

RecruitingIRCT20181022041407N13

Mashhad University of Medical SciencesRheumatoid Arthritis. Other rheumatoid arthritis

Start: 2024-10-22Target: 1Updated: 2025-01-08

The effect of intravenous trehalose on Fatigue in MS

Active, not recruitingIRCT20181022041407N14

Mashhad University of Medical SciencesMultiple Sclerosis. G35

Start: 2025-09-23Target: 1Updated: 2025-07-21